Enterprise

SAS and Posit Partner to Unify Open Source and Governed AI

Integration brings R, Python, and SAS workflows together for clinical development teams under unified governance and regulatory controls.

Omega Editorial · November 16, 2026 · 3 min read

Key takeaways

  • SAS and Posit have integrated their platforms to let clinical development teams use SAS, R, and Python under unified governance and access controls.
  • The partnership connects SAS Viya and SAS Clinical Acceleration with Posit Workbench, Positron, and Package Manager for regulated workflows.
  • Regeneron is already using the integrated platform to eliminate data duplication and access control workarounds in multilingual clinical workflows.
  • Programmers can now write SAS and R code in a single session with AI assistance while maintaining regulatory compliance and audit trails.
  • The integration addresses a longstanding friction point between open source flexibility and the governance requirements of FDA and EMA submissions.

SAS and Posit PBC have formed a partnership to integrate their platforms, enabling life sciences organizations to combine open source data science tools with enterprise governance controls required for clinical development and regulatory submission.

The collaboration connects SAS Viya and SAS Clinical Acceleration with Posit's suite of tools—including Posit Workbench, Positron, Posit Connect, and Posit Package Manager. The integration allows clinical programmers to write SAS and R code within a single development environment while maintaining the access controls, versioning, and audit trails that regulatory bodies demand.

Why it matters

Clinical development teams have historically faced a trade-off: use flexible open source tools like R and Python, or stick with validated SAS environments that meet FDA and EMA requirements. This partnership eliminates that choice by letting teams work across languages under unified governance—addressing a friction point that has slowed adoption of modern data science practices in regulated industries.

How the integration works

The technical foundation centers on direct connectivity between Posit tools and SAS Viya. Programmers can now develop in Positron, Posit's IDE, and execute SAS code through SAS Viya using their own permissions and access rights. Posit Package Manager ensures R and Python environments remain consistent and reproducible across teams, while Posit Assistant provides AI-powered coding assistance that operates within the same governance framework.

SAS Clinical Acceleration, built on the SAS Viya platform, provides a secure clinical data repository and statistical computing environment designed for regulatory submissions. The Posit integration extends these capabilities by adding managed open source environments without compromising transparency or control.

"Life sciences organizations can now bring together the flexibility of open source with the rigor required for regulated clinical research," said Mark Lambrecht, Global Head of Health Care and Life Sciences Solutions at SAS. "Our partnership with Posit will give customers more freedom without compromising the need for transparency and governance."

Real-world application

Regenelon, a biotechnology company, has already deployed the integrated platform. According to Dilip Raghunathan, Business Solutions Partner at Regeneron, the unified environment eliminates previous workarounds that required copying data and duplicating access controls when teams needed to use both R and SAS in the same workflow.

"Now our programmers write both in one session under their own access rights, with AI assistance that works within those same controls," Raghunathan said. "We can tackle complex multilingual workflows seamlessly without overheads that drew us away from the scientific question."

Eric Pite, Senior Vice President of Product and Strategy at Posit, noted that clinical teams specifically requested a solution that would let them use R and Python without sacrificing the controls they rely on in SAS. The companies are now working with joint customers to determine which additional clinical workflows to support.

SAS and Posit representatives are demonstrating the integrated platform at PHUSE EU Connect in Glasgow from November 15-18, 2026. Details of this partnership were first reported by HPC Wire.

  • #sas
  • #posit
  • #clinical trials
  • #life sciences
  • #regulatory compliance
  • #open source

This is an original analysis by the Omega editorial team. Source reporting: AI Watch.

Want systems like this working for your business?

Book a Call

More in Enterprise